Patrick L. Keran - 05 Jan 2023 Form 4 Insider Report for SeaSpine Holdings Corp

Footnote F1

Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 28,986 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.

Footnote F3

The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.

Footnote F4

These restricted stock units were assumed by Orthofix in the merger and replaced by 3,399 Orthofix restricted stock units.

Footnote F5

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F6

The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.

Footnote F7

These restricted stock units were assumed by Orthofix in the merger and replaced by 21,685 Orthofix restricted stock units.

Footnote F8

The option vests as to 25% of the underlying shares on November 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F9

This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $36.23 per share.

Footnote F10

The option vests as to 18.75% of the underlying shares on November 1, 2016, 6.25% on December 31, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F11

This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.

Footnote F12

The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F13

This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,049 shares of Orthofix at a price of $43.82 per share.

Footnote F14

The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F15

This option was assumed by Orthofix in the merger and replaced with an option to purchase 21,979 shares of Orthofix at a price of $28.85 per share.

Footnote F16

The option fully vested and became exercisable on June 21, 2020.

Footnote F17

This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,516 shares of Orthofix at a price of $23.86 per share.

Footnote F18

The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F19

This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,979 shares of Orthofix at a price of $40.50 per share.

Footnote F20

The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.

Footnote F21

This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share.